Pharmaceutical industry news

NCT03269578: Sample Collection and Tracking for the Developmental Therapeutics Clinic

Study type: OBSERVATIONAL. Phase: .

NCT02669225: Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy People

Study type: INTERVENTIONAL. Phase: EARLY_PHASE1.

NCT02544022: Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)

Study type: OBSERVATIONAL. Phase: .

NCT01778543: Pathogenesis and Genetics of Microphthalmia, Anophthalmia and Uveal Coloboma (MAC)

Study type: OBSERVATIONAL. Phase: .

NCT00794352: Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System

Study type: OBSERVATIONAL. Phase: .

NCT00598351: Natural History Study of Patients With Neurofibromatosis Type 2

Study type: OBSERVATIONAL. Phase: .

NCT00007150: Treatment of Hemochromatosis

Study type: INTERVENTIONAL. Phase: PHASE2.

NCT00001471: Tissue Biopsy and Imaging Studies in HIV-Infected Patients

Study type: OBSERVATIONAL. Phase: .

NCT00001467: Genetic Analysis of Immune Disorders

Study type: OBSERVATIONAL. Phase: .

Trump expands his plan to lower drug prices: 26 pharmaceutical companies have now joined

Upfront help cuts placement costs for healthcare students

From 2026 to 2027, eligible healthcare students can get travel and accommodation costs upfront, easi...

Trump touts deals with nine more pharmaceutical companies

Astellas enters voluntary agreement with U.S. government supporting affordable access to medicines

UPDATED: Novartis halts autoimmune CAR-T trials after 3 deaths, as BMS also pauses studies

Column: Drug compounding has changed. Oversight should too

Column: Drug compounding has changed. Oversight should too

Resultados financieros de los nueve primeros meses de 2026

'Without Guardrails': Report shows most physicians don't prescribe abortion pills

ESC 2026: Aficamten breaks new ground in nonobstructive HCM

Trump Announces Nine New Drug Pricing Deals With Pharmaceutical Companies

Tackling the Lingering Questions Surrounding AI Adoption in Clinical Trial Settings

Trump announces drug pricing deals with nine pharmaceutical firms

Trump announces new drug-pricing deals with 9 pharma companies

Federal judge delays a mifepristone lawsuit until after midterms

Florida, Texas Abortion Pill Suit Paused for FDA’s Safety Review

White House unveils next round of MFN pricing deals with 9 midsized drugmakers

WATCH: Trump says more pharmaceutical companies will lower drug prices

White House strikes new drug-pricing deals

Court Lets US Abortion Pill Access Continue—Until Trump FDA Finishes Review Condemned as 'Sham'

Pharmaceutical Defoamers Market Outlook to 2035

Press Release: Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth

Trump announces deal with 9 new pharmaceutical firms in move to ease drug costs

Meet a Whitehead Alum: Alicia Zhou, CEO of the Cancer Research Institute

Trump Administration Adds Nine Drugmakers to Most-Favored-Nation Program: Report

Inventiva Appoints Chris Benecchi as Chief Operating Officer

Veraxa Biotech (VRXA) CEO now holds 5,000 ordinary shares

INVENTIVA

Takeda, Other Biotech Firms to Announce New Drug Pricing Deals With White House

Trump announces deal with pharmaceutical companies to lower drug prices

The FDA cannot inspect its way to a safe global food supply

Trump strikes nine more deals with drugmakers to lower prices

FDA dings Alar over ‘extremely concerning’ ketamine claims

Donald Trump announces pharma deal: List of drugs getting prices reduced

UFRJ aprova criação da Medalha Minerva de Mérito Administrativo para valorizar servidores da ativa

Cancer drug shortages threaten lives as efforts to prevent them hit regulatory red tape

MIT Quantum Initiative launches postdoctoral fellowship program

‘How is Vivek Ramaswamy not in prison?’ Ohio governor candidate accused of multibillion-dollar ‘pump-and-dump’ scheme

Federal judge pauses case on mifepristone access until after midterm elections

Study: Peptides can form well-defined structures in harsh, Venus-like conditions

Eli Lilly Enters $2.8 Billion Agreement to Acquire Merida Biosciences | PharmExec

FDA Clears First Targeted Dermatomyositis Treatment From Roivant

The Global Diagnostic Equity Gap: An Interview with Dr. Philip Angelides

Regulatory Roundup—August 2026

Lilly to acquire biotech firm Merida in $2.87bn deal

Managing Risk Across Clinical Development

Yokogawa SS2000 High Content Imager

FDA Approves Stelara for Pediatric Ulcerative Colitis

Medtronic recall prompts FDA safety alert after 184 serious injuries

IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference

Fulcrum Therapeutics faces securities probe aft...